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Figure 1: Cancer Cells Splitting [1]
”Growth for the sake of growth is the ideology
of the cancer cell.”
Edward Abbey (The Journey Home, 1977)
Abstract
Tumor is an abnormal growth of mass tissue resulting from several and
successive cell divisions without control, caused by modifications in DNA
genome of the triggering cell, i. e. this initial cell suffered several mutations.
To proliferate the tumor has to overcome several external factors such as
the body’s immune system that considers it a foreign body and tries to fight
it, the pressure exerted by the extracellular matrix and adjacent normal cells
and has yet to fully capture all the nutrient needed to feed its cells and thus
enable them to be divided and the tumor can continue to proliferate.
However, the tumor does not grow indefinitely, there is a moment when
the nutrient released from blood vessels and capillaries present within the
body is no longer enough to feed all the tumor cells and some begin to die,
usually is the center of the tumor that becomes necrotic.
In principle, at this time the tumor ceases to grow reaching an equilibrium
state where the cells that die at each time offset the new cells formed.
This steady state occurs when the tumor reaches approximately 2 mm in
diameter and at that time the tumor develops new skills that allows it to
continue proliferating. May be through the induction of angiogenesis, the
movement in the body or can become malignant and metastasize.
The work developed on this project aims to simulate the evolution of the
tumor until the time it reaches the steady state and is able to produce VEGF
to induce the formation of a new capillary network that will provide it all
the support and necessary food.
The mathematical model used is continuous and multi-phase, taking into
account that the tumor growth is nutrient limited.
The system has two cell phases, characterized by an order parameter φ,
one phase is compound of tumor cells (φ = 1) and the other is compound of
normal cells (φ = −1). This system has a blood vessel located at one end
and provides nutrient at each time step, nutrient starting condition is linear.
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For the tumor, the initial condition is circular and has a well defined inter-
face that penalizes the spatial variations of phase, avoiding unwanted phase
fluctuations around it. The model also considers the cell density, which
reproduces more effectively the surrounding environment of the tumor.
The results present the study of the tumor’s evolution according to the
rates of growth and apoptosis, and depending on the mobility of the cellular
matrix too. The goal was to verify that the tumor eventually cease their
growth at a certain moment. What we observe is that at a given time
the tumor began to stop growing and reach the steady state, but at that
moment moves towards the capillary in order to get more nutrients and to
grow again.
It was verified that the movement towards the capillary is an effective way
for the tumor to continue proliferating.
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Resumo
Tumor e´ o crescimento anormal de uma massa de tecido resultante de
va´rias diviso˜es celulares sucessivas sem controlo, originadas por alterac¸o˜es
no genoma do DNA da ce´lula precurssora, ou seja esta ce´lula inicial sofreu
va´rias mutac¸o˜es.
Para proliferar o tumor tem de vencer diversos factores externos, tais como
o sistema imunita´rio do organismo que o considera um corpo estranho e tenta
combateˆ-lo, a pressa˜o exercida pela matriz extracelular e pelas ce´lulas nor-
mais adjacentes e tem ainda de conseguir captar todo o nutriente necessa´rio
para alimentar as suas ce´lulas e possibilitar deste modo que elas se dividam
e o tumor possa continuar a proliferar.
Contudo o tumor na˜o cresce indefinidamente, ha´ um momento em que
o nutriente libertado pelos vasos e capilares sangu´ıneos presentes naquela
zona do organismo ja´ na˜o e´ suficiente para alimentar todas as ce´lulas do
tumor e algumas comec¸am a morrer, geralmente o centro do tumor torna-se
necro´tico.
Em principio, nesta altura o tumor deixa de crescer atingindo-se um es-
tado de equilibrio em que as ce´lulas que morrem em cada instante compen-
sam as novas ce´lulas formadas.
Esse estado estaciona´rio ocorre quando o tumor atinge cerca de 2 mm
de diaˆmetro e nesse momento o tumor desenvolve novas caracter´ısticas que
lhe permitem continuar a proliferar. Pode ser atrave´s da induc¸a˜o de an-
gioge´nese, da deslocac¸a˜o no organismo ou pode tornar-se maligno e metastizar-
se.
O trabalho desenvolvido neste projecto pretende simular a evoluc¸a˜o do
tumor ate´ ao momento em que este atinge o estado estaciona´rio e se encontra
em condic¸o˜es de produzir VEGF para induzir a formac¸a˜o de uma nova rede
de capilares que lhe fornecera˜o todo o suporte e alimento necessa´rio.
O modelo matema´tico desenvolvido e´ cont´ınuo e multi-fase, tendo em
considerac¸a˜o que o crescimento tumoral e´ limitado pelo nutriente.
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O sistema possui duas fases celulares, caracterizadas pelo paraˆmetro de
ordem φ, uma fase composta pelas ce´lulas normais (φ = −1) e a outra pelas
ce´lulas tumorais (φ = 1). Este sistema possui um vaso sangu´ıneo que se
encontra num dos extremos e fornece nutriente em todas as iteracc¸o˜es, tendo
uma condic¸a˜o inicial linear. Quanto ao tumor a sua condic¸a˜o inicial e´ circular
e possui uma interface bem definida que penaliza as variac¸o˜es espaciais de
fase, evitando flutuac¸o˜es de fase indesejadas em torno da mesma. O modelo
considera tambe´m a densidade celular, reproduzindo assim de forma mais
eficaz o ambiente circundante do tumor.
Os resultados apresentam o estudo da variac¸a˜o da evoluc¸a˜o do tumor em
func¸a˜o das taxas de crescimento e apoptose das ce´lulas de tumor, bem como
em func¸a˜o da mobilidade da matriz celular. O objectivo era verificar que o
tumor acaba por cessar o crescimento num determinado momento. O que
se observou foi que o tumor quando estava a parar de crescer e a atingir
o estado estaciona´rio se movia em direcc¸a˜o ao capilar de modo a conseguir
mais nutriente e poder crescer novamente.
Foi verificado que a deslocac¸a˜o em direcc¸aˆo ao capilar e´ uma forma eficaz
do tumor continuar a sua proliferac¸a˜o.
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1 Introduction
1.1 General Aspects
All over the word millions of people live with cancer diagnosis, so it is
unquestionable the need to pursue the research within this topic.
Cancer is responsible for one in eight deaths worldwide[2]. This includes
more than 100 different diseases with high diversity of epidemiology and
risk factors that reaches the majority of cell types and organs of the human
body. Cancer is characterized by a disorderly proliferation that may exceed
the limits of normal tissue and metastasize to distant organs. All cancers
arise as a result of changes in DNA sequence of the cancer cells genome [3].
Drugs that aim to block the blood supply to tumors, known as angiogen-
esis inhibitors, have been blamed for being started a new era in the cancer
therapy. Targeting the blood vessels that feed tumors was not the solution
expected to fight tumors, but refinements in strategy may suggest important
ways to treat the disease [4, 5, 6, 7].
Models that are purely in vitro, such as focus formation and anchorage-
independent growth (term used to characterize cells that do not require a
solid substratum for growth, i.e., the solid glass or plastic surface of a cul-
ture dish or micro-carrier beads. Such cells can be grown in suspension or
soft media in which they float freely [8]), are not particularly adjustable to
study the relationship and evolution of tumor cells in their biological mi-
croenvironment, the crucial game between cancer cells and different types
of surrounding normal cells or even for testing the potential efficacy of ther-
apies directed at the tumor microenvironment[9].
In vivo studies of tumors are challenging due to the small size of animal
models and because most of the time what was observed is the interaction
between the human tumor cells and the animal organism. There are some
interesting in vivo platforms for studying the tumor growth within an human
cellular microenvironment by developing a teratoma into an immunocom-
promised mouse[9]. But even in that cases the tumor requires time to grow
naturally.
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The tumor cell’s characteristics could change and adapt themselves to the
surrounding microenvironment in order to survive and proliferate [10, 11].
A computational model may not reproduce all the biological variables, but
could help to characterize and quantify those variables.
These are some of the reasons that lead to the importance of designing a
computational model that is able to simulate tumor growth before and after
angiogenesis induction.
1.2 Objectives
Cancer may not be the most important cause of death in the world, but it
is still on the top of those causes[2]. It is very important to understand how
a tumor develops and induces angiogenesis to keep increasing its volume,
since if it does not induce the promotion of its own capillary network it
remains in a stationary state, and may even decreases its size.
The main objective of this work is to simulate the tumor’s growth and
movement from an initial state, when blood supply from a pre-existent vessel
is enough, to its critical volume, when tumor releases Vascular Endothelial
Growth Factor (VEGF) in order to induce angiogenesis and provide its own
blood supply.
It is important to study and analyse the favorable conditions for tumor
growth and what happens within its biological microenvironment in order to
stop the growth. One of the most important stages of the tumor evolution
is when it achieves a steady state and induces angiogenesis or develops new
skills to continue growing, like migrating on the organism in order to arrive
in a densely vascularized and well-perfused organ, such as brain, liver, lung
or kidneys.
2
2 Theoretical Background
2.1 Introduction
The cells are the structural and functional units of all known life forms
and are the smallest unit of an organism that is considered living.
The cell’s renovation and repair involves proliferation and cell differentia-
tion. Proliferation is the process of cell division, it is an adaptive mechanism
inherent to body cell’s replacement and occurs as a consequence of cell death
or additional need of cells in the body. Differentiation is the specialization’s
process by which new cells acquire the structure and function of the cells
that they will replace [12].
In adult tissues, the size of a cell population is determined by the rates
of proliferation (process of cell division), differentiation (process of cell spe-
cialization/maturation) and death by apoptosis (process of cellular self de-
struction) [12, 13, 14, 15].
In normal tissue proliferation is a regulated process that allows the equi-
librium between new cells formation and apoptosis [12], but in biology all
the rules have exceptions, and tissue proliferation is not always perfect.
The cell cycle, or cell-division cycle, is characterized by four distinct
phases: G1 phase, S phase, G2 phase (also known as interphase) and M
phase. M phase is itself composed of two tightly coupled processes, that
are mitosis, in which the cell’s chromosomes are divided between the two
daughter cells, and cytokinesis, in which the cell’s cytoplasm divides forming
two distinct cells [13, 16].
In G1 phase cells increase in size. The mechanism of G1 checkpoint control
verify and ensure that all conditions are favorable to the beginning of DNA
synthesis. The DNA replication occurs during the S phase [13].
During the G2 phase cells continue to grow. The mechanism of G2 check-
point control determines if the cell is ready to begin dividing. In the mitotic
phase, the cell growth ceases and starts an orderly division of the initial
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Figure 2: Cell Cycle Overview[17]
cell into two daughter cells. In the middle of mitosis is ascertained that cell
division can be completed by a checkpoint [13].
Activation and begining of each phase is dependent on the proper pro-
gression and completion of the previous one.
Cells that have temporarily or reversibly stopped dividing, have entered
in a quiescence state also called G0 phase. That is a resting phase where
the cell has left the cycle and stopped dividing. [13] (see Fig. 2).
The deregulation of several cell cycle components may lead to tumor for-
mation. Many oncogenes regulate the cell cycle and a mutation of one
of these may induce the cell to multiply uncontrollably, forming a tumor
[12, 15].
Although the duration of cell cycle in tumor cells is equal to or longer
than normal cell cycle, the proportion of cells that are in active cell division
(versus quiescent cells in G0 phase) in tumors is much higher than that in
normal tissues [12, 13].
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2.2 Cell Growth
The body tissues grow by increasing the number of cells that compose
them. In an adult specimen most cells only reproduce themselves in order
to replace others that have died or undergone damage, for example through
injury or illness [14, 15, 18].
Not all cells have the ability to reproduce, most of them became mature
and specialize in their particular job in the body. These mature cells loose
the ability to reproduce as they develop. However there will always be
enough stem cells around, that are undifferentiated, to replace cells that are
damaged or killed [18, 19].
The normal cells growth and healing is a very regulated and precise
process, regulated by chemical factors and intrinsic factors of cells.
In opposition to tumors, normal cells have a natural ability to stick to-
gether in the right place; this phenomenon is called cell adhesion. Molecules
on the cell surface, are in contact with the molecules of the neighboring cells
surfaces [19].
If the genes of a cell are very badly damaged, or if it becomes dissociated
from its proper place, the cell will self destruct by the apoptosis process.
A deeper understanding of the cell apoptosis mechanism and of its possible
shortcomings will help the development of cancer treatments in the future
[5, 19].
The tumor cells may develop the ability to avoid apoptosis, in which case
the cells do not self destroy [14, 20, 21]. However they can not prevent
necrosis, which is the premature cell death, but when caused by external
factors such as lack of blood supply [21].
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2.3 Tumors
The common definition for Tumor is an abnormal growth of mass tissue,
due to several cell’s divisions without control after an initial cell mutation
(DNA genome modification) [21, 22, 23]. Tumors can be cancerous (malig-
nant) or non-cancerous (benignant).
However, a tumor is not a homogeneous mass composed of the same type
of cancer cells multiplied indefinitely. It consists of cancer stem cells, ma-
ture, metastatic, stromal, endotheliais, etc..all embedded in an extracellular
matrix [10]. In tumor cells two or more of those characteristics are absent
[21].
The normal body cells have some important characteristics, like the ability
to control and regulate their proliferation, stick together, become specialised
or ’mature’ and self destruct if any of these mechanisms is malfunctioning.
In tumor cells two or more of these characteristics are not present. A tumor
cell is not the result of a single genetic mutation but of several ones in genes
regulating pivotal processes for the good functioning of the cell [14, 21, 24].
Tumor cells can survive if they move to another part of the body, and
may not stop reproducing after they had double 50 or 60 times. The cancer
cells are normally able to prevent themselves from apoptosis, or may self
destruct more slowly than they reproduce, so that their numbers continue
to increase [20, 24, 25, 26].
Cancer cells do not self destruct because the genes that regulate apoptosis
are damaged or lost. So long as there is space and nutrients, the tumor cells
continue to replicate itself, regardless of the extra damage that they can
cause to the tissue where the tumor is located [21].
In addition cancer cells don’t stick together, since they often lose the
signaling molecules on their surface that keep normal cells in the right place.
So they can become detached from their neighbours and in part this explains
how cancer cells spread to other parts of the body, forming metastasis (see
figure 3) [20, 25, 27].
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Figure 3: Tumor cells proliferation [28]
Initially, tumors do not have their own blood supply and need to be close
to a blood vessel that provides them with oxygen, nutrients and allows waste
products removal [23, 29].
As the tumor grows it demands more nutrients and the existing blood
supply is not enough for all tumor mass requirement. So some cells become
necrotic and counterbalance the tumor cells proliferation. It stops to grow
and achieves a steady state, that corresponds to its critical size [21, 30, 31,
32].
However, tumors as defensive action may either move towards the capil-
lary or start to release VEGF, which promotes the new capillary formation
by a process called angiogenesis, check the angiogenesis induction in figure
3 [25, 30, 31, 33, 34].
Malignant tumors can be classified into two types with respect to the
pattern of growth: expansive and infiltrative lesions [35].
The expansive, not infiltrative, are tumors dependent on angiogenesis to
get nutrients and oxygen, because this type of growth pattern is charac-
terized by intercellular adhesion molecules that keep cancer cells together
to avoid migration. Infiltrative tumors may exploit pre-existing vasculature
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through a process called co-option and thus grow without need of angiogen-
esis if they migrate to a densely vascularized, well perfused organ. However,
they may also induce angiogenesis [35, 36].
We can sort the overview in figure 3 as an expansive tumor that induced
angiogenesis to be more efficient in their proliferation.
2.4 Angiogenesis
Angiogenesis is the process that allows the formation of new blood vessels
from pre-existing vessels and occurs in different stages of our life. The blood
vessels inside wall is formed by vascular endothelial cells. These cells rarely
divide, doing that only about once every 3 years on average. However,
when the situation requires it, angiogenesis can stimulate them to divide
[30, 31, 37].
Angiogenesis is not only a process induced by tumors, being normal both
in children and in adults. In addition to its role in tumors, angiogenesis
occurs normally in the human body at specific times in development and
growth [37, 38].
Angiogenesis is the result of a delicate balance between Anti and Pro an-
giogenic factors [31]. When this equilibrium is disturbed, then an abnormal
capillary network is formed being characterized by capillaries of variable
width, not organized in an hierarchical network and with very permeable
walls (see Fig. 4) [30, 31, 32, 39].
For example, a developing child in the mother’s womb must create the
vast network of arteries, veins, and capillaries that are found in the human
body. A process called vasculogenesis creates the primary network of vascu-
lar endothelial cells that will become major blood vessels. Later on, through
angiogenesis sprout out from the existing vessels, new vessels or capillaries
that complete the child’s circulatory system [38].
Creation of new blood vessels also takes place in adults, although it is a
relatively infrequent event. In women, angiogenesis is active a few days each
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Figure 4: Angiogenesis: Anti and Pro angiogenic factors balance [41]
month as new blood vessels form in the lining of the uterus during the men-
strual cycle. Also, angiogenesis is necessary for the repair or regeneration of
tissue during wound healing [37].
Tumor angiogenesis is the proliferation of a network of blood vessels that
penetrates into the cancerous mass, supplying nutrients and oxygen and
removing waste products. Tumor angiogenesis actually starts with cancerous
tumor cells releasing molecules that send signals to surrounding normal host
tissue [6, 30, 31, 40].
When the solid tumor reaches a critical proportion (about 2 mm diameter)
and is still nonvascular, it starts to produce and release VEGF. This factor
is a chemical factor (polypeptide) produced by tumor cells, as a result of
hypoxia, that interacts with a nearby vessel and promotes the creation of
the network of new blood vessels [6, 21, 31, 33].
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2.5 Mathematical Model Overview
Many aspects of tumor and tissue growth have been studied using math-
ematical models.
Mathematical model can be classified in continuum and discrete approaches,
as well as so called hybrids, which combine both the techniques in one form
or another [42, 43].
Since much of the information about cells is collected at the cellular and
sub-cellular level, ideally, what is needed is a rigorous derivation of large-
scale continuum models from individual-based models that may more easily
be based on well-founded experimental information. In this way it should be
possible to ensure that small-scale properties relevant for the large scales are
retained and to quantify the validity of the continuum equations for finite
population sizes [44, 45].
However, the mathematical techniques that allow rigorous derivations of
continuum models from agent based models exist in only a very limited
number of cases [44, 46].
In those cases for which it is not possible to relate the agent-based and
continuum models at intermediate population sizes, some progress can be
made by comparing their spatial-temporal dynamics. While normally fo-
cusing on compact monolayers, growing on a flat substrate, the models can
readily be extended to three dimensions [44, 46, 47].
The main features of a discrete model is based on its ability to investigate
the dynamics of a tumor at the cellular and subcellular level. The cells
are autonomous and have a set of rules that characterize their behavior.
However these models are limited to a comparably smaller scale due to
prohibitive computational costs [45].
Discrete models are generally represented by a cellular automaton (CA),
since they describe a spatial matrix in which the dynamics between cells and
their ”neighbors” are defined by a set of local rules that may also decide the
transition and communication between the grid points. Normally each point
on the grid represents an individual agent or a cluster of agents [44].
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Continuum models in turn describe the tumor tissue as a continuous
medium, being able to capture larger scales of volumetric tumor dynamics
and are computational cost efficient. However have limitations in the im-
plementation of interactions between heterogeneous cell-microenvironment
and cell-cell dynamics, and even to describe the dynamics at the molecular
level [44, 45].
Therefore, hybrid models have become popular due to their ability to
allow for tumor simulations across multiple scales in space and time [42].
The hybrid models span a large range of scales but are rather complex to
program and have many fitting parameters [45].
However, when we consider several cellular phases and we want to describe
the interface dynamics, the phase-field method is particularly useful. The
phase-field is a mathematical tool that converts the problem of having a
mobile boundary at the sharp interface in a set of easily treatable differential
equations for an order parameter φ that is continuous in space but has
different constantvalues at each phase [48, 49, 50].
The correct interface dynamics is obtained when the interface width be-
comes small compared with its curvature radius. Phase-field models are very
tailorable because allow the change of the energy related to the interface,
as well as the way the partial differential equations are written in order to
describe a vast range of systems [48, 50].
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3 Description of Computational Model
3.1 Nutrient Diffusion and Model General Aspects
The computational model that has being developed is a continuum model.
The program design is developed using Fortran 90 and the model simulates
the tumor’s growth before it induces angiogenesis.
Tumor growth is nutrient limited, the tissues get nutrients and oxygen
through the blood vessels walls and diffusing in the extracellular matrix
(ECM) in order to arrive into the cells. When the tumor cells cluster and
form a multicellular spheroid, they receive the nutrients through the bound-
ary and the nutrient diffuses toward the center of the tumor [23, 49].
The model considers nutrient diffusion from a blood vessel, located in
the far right, the concentration of nutrients at the vessel is kept equal to
1 throughout the simulation, which means that there is a continuous flow
of blood in the capillary and nutrient concentration at the vessel is not a
function of how much nutrients are consumed at each iteraction by the tissue
cells. The type of cells at a point in the tissue is described through an order
parameter φ. Tumor cells have φ = 1 and other cells φ = −1.
This is a multiphase model, considering the tumor cells as one phase and
the surrounding tissue (normal cells) as another phase. It doesn’t consider
a separate phase for the extracellular matrix, which is where the nutrient
diffuses to achieve the cells, so in the model the nutrient concentration is
independent of the cell concentration. This approximation is also used in
models which consider the ECM as a separate phase.
The diffusion equation (1) considers the nutrient diffusion in the tissue
and nutrient consumption by the tissue cells at rate αc(φ) (2). Since φ is
the order parameter that describes the type of cells, this means that the
rate of nutrient consumption depends on the type of cell.
∂tn(−→r , t) = D∇2n(−→r , t)− αc(φ) (1)
αc(φ) =
{
0.0014 , φ ≤ 0
0.14 , φ > 0
(2)
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Figure 5: Nutrient Initial Condition
At each iteration the blood vessel provides nutrients to all the tissue sur-
face. The starting condition for the nutrient is linear, from 0 to 1 at the
capillary (see Fig. 5), which avoid that a large number of tumor cells die
at the onset of the simulation. When the nutrient conditions are propitious
the tumor proliferates.
In Figure 5 we see the distribution of nutrient on the basis of cartesian
coordinates, and the outlook for −→r = (x; 0).
If the nutrients concentration falls below a threshold value then the cells
are unable to survive and undergo necrosis, generating a necrotic core. From
in vitro experiments is concluded that avascular tumors possibly reach an
equilibrium around 2 mm in diameter [21, 31], at which the rates of prolifer-
ation and necrosis averaged over the tumor volume are identical. Typically,
at that stage the tumor contains an outer rim of proliferating cells, a central
necrotic core and an intermediate region of quiescent cells, that are alive but
not proliferating due to deprivation of nutrient [23].
The tumor cell’s consumption rate is an hundred times superior to the
normal cells consumption and it is imposed that nutrients concentration
can not be negative. In the model the nutrient threshold for the tumor cells
death is the absence of nutrient.
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Figure 6: Cell Phases Initial Condition
3.2 Cell Proliferation: First Model
Initially the model did not consider the effects of pressure exerted by the
interaction between cells, because the total cell density was kept constant.
The starting condition consists of a small circular tumor (radius (r) is set
equal to 10 lattice units) at a distance from the existent vessel (see Fig. 6).
The equation that describes the location of the tumor and the shape of
the interface between the two cell phases:
φ(−→r , t) = − tanh(
√
(x− 25)2 + (y − 50)2 − r) (3)
In Fig.7, the red curve is obtained by the simulation, the blue curve is a
representation of the previous equation and the green line (φ = 0) intersects
the curves at the point of phase separation.
The interface between two cell types costs energy
√
2ǫ/3 per unit length,
where ǫ is the interface width. This interface ensures that spatial variations
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Figure 7: Interface Profile
of phase, different phases next to each other, are penalized, avoiding unde-
sirable fluctuations around the interface. The equations for the evolution of
φ in time are the following:
∂tφ(−→r , t) = ∇M(φ) · ∇µ(φ) + αr(n, φ) (4)
where the chemical potential is given by:
µ(φ) = −φ(−→r , t) + φ3(−→r , t)− ε2∇2φ(−→r , t) (5)
The equation of the chemical potential is derived in Appendix A.
In the fourth equation the parameter αr(n, φ) is introduced to describe
the cells evolution, it is a proliferation factor. With favorable nutrient con-
ditions, the tumor grows at rate G otherwise cells die at rate A. Normal
cells have this reproduction rate kept equal to zero because it is assumed
that they reproduce and die at the same rate, maintaining the equilibrium.
αr(φ, n) =


G ,φ ≥ 0 , n > 0
−A ,φ > −1 , n = 0
0 , φ < 0 , n > 0
(6)
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Factor M(φ), describes the cells mobility and was introduced to reproduce
the fact that normal tissue cells form an ordered lattice, while tumor cells,
being more spatially disorganized, may have a larger mobility.
M(φ) =
{
1 , φ ≥ 0
0.1 , φ < 0
(7)
In order to conserve the total φ, that are imposed mirror conditions at
the simulation box walls.
3.3 Cell Proliferation: Second Model
The model describes the type of cells at a point in the tissue through an
order parameter φ like in the first model, but in this case we introduce a
new equation for total cell density ρ(−→r , t) (see equation 8 and following).
The following equations describe the evolution of φ and ρ in time (deduc-
tions are in Appendix B):
∂tρ(−→r , t) =Mρ∇2ρ(−→r , t)) + L(φ, ρ, n) (8)
∂tφ(−→r , t) = −M(ρ)
ρ(−→r , t)φ(
−→r , t)∇2ρ(−→r , t) + Mφ
ρ(−→r , t)∇
2µ(φ) +
+
M(ρ)
ρ(−→r , t)∇
2(φ(−→r , t)ρ(−→r , t)) +G(φ, ρ, n) (9)
∂t(φ(−→r , t)ρ(−→r , t)) =Mφ∇2µ(φ)+Mρ∇2(φ(−→r , t)ρ(−→r , t))+H(φ, ρ, n) (10)
To see the deductions of equations 10 and 11 appeal to Appendix C.
Factor Mφ, describes the cells mobility and their ability to phase separate.
we can make it φ dependent in order to reproduce the fact that normal
tissue cells form an ordered lattice, while tumor cells being more spacially
disorganized, may have a large mobility. The Mρ factor is kept equal to 1
but could also be made φ dependent.
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In the equation 11 the parameter H(φ, ρ, n) is introduced to express the
cells evolution, it is a proliferation factor, and is described by:
H(φ, ρ, n) = ρG(φ, ρ, n) + φL(φ, ρ, n) (11)
Where G(φ, ρ, n) and L(φ, ρ, n) are given by:
G(φ, ρ, n) =


Gφ(−→r , t)(1 − φ(−→r , t))(1 − ρ(−→r , t)) , φ ≥ 0, n > 0
−A(1− φ2(−→r , t)) , φ > −1, n = 0
0 , φ < 0, n > 0
(12)
L(φ, ρ, n) =


Gφ(−→r , t)ρ(−→r , t)(1− ρ(−→r , t)) , φ ≥ 0, n > 0
−Aρ(−→r , t)(1 + φ(−→r , t)) , φ > −1, n = 0
0 , φ < 0, n > 0
(13)
These equations represent the growth (and death) factors, respectively for
the order parameter and for density parameter (equation 12 is derived in
Appendix B). G and A are respectively the growth and necrosis rate of the
cells. Normal cells have the proliferation rate kept equal to 0, because it
is assumed that they reproduce and die at the same rate, maintaining the
equilibrium.
We define also the parameters ρ and φ in order to the tumor cells density
(ρt) and the normal cells density (ρn), through the equations:
ρ = ρt + ρn (14)
and:
φ =
ρt − ρn
ρt + ρn
(15)
The density at each point in space corresponds to the total density of nor-
mal and tumor cells. The expression for the order parameter φ ensure that
the amount of normal cells over time, in the total space, remains constant.
In order to conserve the total φ, that are imposed mirror conditions at
the simulation box walls like in First Model.
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Parameters Values
x 100
y 100
r 10
D 35
α 0.014
ε 1
Mρ 1
∆(t) 1.28·10−4
Table 1: Values for the simulations.
4 Simulation’s Results/Discussion
4.1 Nutrient Diffusion
Both models assume that the initial condition of the distribution of nutri-
ents in the system is linear, but despite this condition some cells initially die
before the regular growth profile emerges. Until the system stabilizes, the
consumption of tumor cells is always higher than the diffusion of nutrients
in the space.
The values for the diffusion (D) and consumption (α) rates were defined to
assure that after a time t=50 (equivalent to 390000 iterations) the nutrient
concentration value at half tissue surface is about 0.5 (see Fig. 8) like in the
initial condition (see Fig. 5). After that time we can consider that nutrient
diffusion in the system is stable and the changes at the tumor are due to the
dynamics between growth and death rates and also the dynamics between
the two cell phases (normal cells and tumor cells).
As we can see at figure 9 and at all the figures regarding the distribution
of nutrients on the space, the distribution has a darker region corresponding
to a low nutrient concentration at the location of the tumor, which consumes
more nutrients than the rest of the tissue in each time step.
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Figure 8: Nutrient diffusion at t=50: A = 0.05, G = 0.2 and Mφ = 10.
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Figure 9: Nutrient diffusion at t=50: A = 0.05, G = 0.2 and Mφ = 10.
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Figure 10: Nutrient diffusion at t=2000, Mφ = 10: A = 0.1, G = 0.01(left)
and A = 0.01, G = 0.1(right)
Normal cells do not grow or die in the presence or absence of nutrient,
respectively, however the tumor cells reproduce if there is enough nutrients
and die in the absence of nutrient.
The relationship between the rates of necrosis (A) and growth (G) deter-
mines the levels of nutrients that may exist in phase space at the differents
simulations.
From one simulation to another, the variables that can be changed are
the mobility and the proliferation rates.
If A is too high (and G is preferably low) in the absence of nutrient tumor
cells die very quickly, which may disappear, so that the nutrient level is
virtually constant throughout the space and close to 1 (see Fig. 10 (left)).
If instead the growth rate is higher and A is reduced, then it appears that
the tumor proliferates and nutrient levels remain low in the tumor, close or
equal to 0 (see Fig. 10 (right)), which leads to tumor cells death and allows
that the nutrient levels rise back above the threshold. This balance between
tumor cell death and nutrient levels will be explained in more detail later
on.
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4.2 Cells proliferation for the First Model
At this stage the model consider that the mobility of normal cells is very
small (M=0.1), so that they do not have large freedom of movement and
hinder the intrusion of the tumor cells, although the latter have high mobility
(M=1). In this way we ensure that there is not spreading of tumor cells in
normal tissue, but they proliferate as a whole.
These differences in mobility between the two phases were introduced in
a way to reproduce the effects of pressure that are observed in biological
systems.
During the simulations, regardless of the values chosen for the variable
parameters (A and G), it was observed that as expected, the tumor tries to
occupy space and moves to places with higher concentration of nutrients in
the direction of the blood vessel.
Another interesting fact observed at figures 11, 12 and 13 is that the cells
of the center of the tumor are the first to suffer necrosis. That creates a
necrotic core, cells no longer behave like tumor cells and thus do not require
such a high amount of nutrients allowing the tumor cells nearby have more
food and proliferate.
At this first situation the apoptosis rate is higher than growth rate, so
despite having a linear initial condition of nutrient, the tumor has not enough
nutrients to feed its cells at the begining and disappear after t=50.
Reducing the A we can see in figures 14, 15 and 16 that the tumor grows
and even move slightly but as A is also low it does not move a lot. Another
interesting aspect is that as the rates of proliferation are low and balance
themselves, the first cells to die are those that are further away from high
concentrations of nutrients.
However at figures 17, 18 and 19 we increase the growth rate and because
the death rate is low, the tumor grows very quickly and reaches the capillary.
At this point it can get all the nutrients it needs and occupies almost all the
space.
21
-1
-0.5
 0
 0.5
 1
-1
-0.5
 0
 0.5
 1
Figure 11: Cells Phases at t=10 (left) and t=20 (right), G=0.01 and A=0.1
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Figure 12: Cells Phases at t=30 (left) and t=40 (right), G=0.01 and A=0.1
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Figure 13: Cells Phases at t=50 (left) and t=60 (right), G=0.01 and A=0.1
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Figure 14: Cells Phases at t=10 (left) and t=100 (right), G=0.01 and
A=0.01
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Figure 15: Cells Phases at t=200 (left) and t=500 (right), G=0.01 and
A=0.01
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Figure 16: Cells Phases at t=800 (left) and t=1000 (right), G=0.01 and
A=0.01
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Figure 17: Cells Phases at t=10 (left) and t=50 (right), G=0.1 and A=0.01
-1
-0.5
 0
 0.5
 1
-1
-0.5
 0
 0.5
 1
Figure 18: Cells Phases at t=100 (left) and t=200 (right), G=0.1 and
A=0.01
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Figure 19: Cells Phases at t=250 (left) and t=300 (right), G=0.1 and
A=0.01
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4.3 Cells proliferation for the Second Model
At this stage the model considers the cell density. The initial condition is
that the cell density in all space is equal to 0.5, regardless of whether they
are normal or tumor cells.
In areas where only normal cells coexist density remains equal to 0.5, but
at the space occupied by the tumor the cell density may increase and even
reach its maximum value ρ = 1.
To calculate the density of tumor cells in all the space we use the equation:
〈ρt〉 = 〈ρφ〉+ 〈ρ〉
2
(16)
The graph that is obtained from (12) gives us a temporal evolution of the
tumor cells density in space. What allows us to infer more clearly if the
tumor proliferated or not.
The parameters that are the variables at this stage are the mobility of the
phase-separating cells (Mφ), the necrosis (A) and the growth (G) rates.
If A is very high, regardless of G be large or small, the tumor cells start
to die at the begining (before nutrient diffusion stabilizes) and the tumor
can not recover and eventually disappears.
If both rates are relatively low and similar, the tumor maintains the initial
shape during its proliferation and does not grow or move much.
However, if A is low and G is very high, the tumor grows quickly, occupy-
ing adjacent spaces and moves in space in order to achieve higher concentra-
tions of nutrients, moving in the direction of the blood vessel and eventually
achieving it.
About how the tumor develops according to the rates of proliferation we
had already talked in section 4.2 so in this section we will focus more on the
analysis of mobility.
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Figure 20: Cells Phases at t=10 (left) and t=100 (right), Mφ=1, G=0.1 and
A=0.01
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Figure 21: Cells Phases at t=500 (left) and t=1000 (right), Mφ=1, G=0.1
and A=0.01
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Figure 22: Cells Phases at t=1500 (left) and t=2000 (right), Mφ=1, G=0.1
and A=0.01
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Figure 23: Evolution of ρt in time: Mφ=1, G=0.1 and A=0.01
The graphs sequence of figures 20, 21 and 22 show the evolution of cell
phases when Mφ is small (equal to 1). We notice that the phase separation
with the progress in time is not very clear, i. e. the interface between tumor
cells and normal cells is not sharp and tumor cells get out of the tumor
region.
In accordance with the rates of proliferation, and as expected, the tumor
grows rapidly and moves towards the capillary. Because with this mobility
the cells have great freedom of movement, the tumor acquires the shape that
allows it to keep the largest number of cells in contact with high concentra-
tions of nutrients.
Increasing the mobility factor, we can observe at figures 24, 25 and 26
where Mφ=10, that there is a clearer phase separation, because the the phase
separation is faster than the density homogeneization. Due to this reason,
and despite the tumor growing and moving towards the blood vessel, its
shape remains similar to the original shape.
The way that the tumor found to combat the lack of nutrient was to move
in space.
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Figure 24: Cells Phases at t=10 (left) and t=100 (right), Mφ=10, G=0.1
and A=0.01
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Figure 25: Cells Phases at t=500 (left) and t=1000 (right), Mφ=10, G=0.1
and A=0.01
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Figure 26: Cells Phases at t=1500 (left) and t=2000 (right), Mφ=10, G=0.1
and A=0.01
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Figure 27: Evolution of ρt in time: Mφ=10, G=0.1 and A=0.01
In the two previous situations A is very low and G is high so the tumor
cells have the need to proliferate and as the death rate is slow, the density
of tumor cells increase significantly.
In figures 23 and 27, we can check that ρt increases in the time, for both
previous situations. For a smaller Mφ there is a higher density of tumor cells
in space during all the time, since the tumor is not confined to the tumor
region it can reach the capillary earlier and grow faster.
In these conditions, tumor will not stop growing how is natural in avas-
cular tumors, because it can move fast and achieve always the amount of
nutrient it needs to feed the cells and to continue moving until reaches the
blood vessel.
For this set of results, we only can conclude that a higher cell motility
represent better the biological conditions of pressure exerted by the external
environment of the tumor.
It also characterizes better the behavior of the cells by defining the cellular
phase separation.
29
-1
-0.5
 0
 0.5
 1
-1
-0.5
 0
 0.5
 1
Figure 28: Cells Phases at t=10 (left) and t=100 (right), Mφ=10, G=0.01
and A=0.1
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Figure 29: Cells Phases at t=200 (left) and t=300 (right), Mφ=10, G=0.01
and A=0.1
Maintaining high cell motility, which focuses on the representation of bi-
ological conditions, if we study the case of having small G and large A (see
figures 28 and 29), what we notice is that the tumor disappears after an
estimated time t=250.
Since the tumor cells have a limited freedom of movement and normal cells
precludes the tumor growth, and the growth rate is reduced, the tumor never
recovers from the initial phase in which the nutrient diffusion has not been
yet stabilized (for t<50) and the cells will die until the tumor disappears.
For high motility (like Mφ ≥ 10) if death rate is large, even if we have
a growth rate high too, the tumor cells disappear because they can not
overcome the death at the early stage.
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Figure 30: Cells Phases at t=10 (left) and t=100 (right), Mφ=5, G=0.05
and A=0.05
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Figure 31: Cells Phases at t=500 (left) and t=1000 (right), Mφ=5, G=0.05
and A=0.05
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Figure 32: Cells Phases at t=1500 (left) and t=2000 (right), Mφ=5, G=0.05
and A=0.05
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Figure 33: Evolution of ρt in time: Mφ=5, G=0.05 and A=0.05
Choosing an intermediate value for the mobility (Mφ =5) and in the case
of figures 30, 31 and 32 if we define that the rates of proliferation and death
are both small and equal, we obtain that the tumor almost achieves the
steady state.
Initially the tumor suffer a reduction in its size, for the reasons already
outlined above, but as A is low the tumor can recover. We can also notice
that as the mobility is not very high, there is not a total separation of
cells phases because the color of the normal tissue is not black any longer,
however these changes are minimal.
To corroborate what we observed in the previous figures we will focus now
on the figure 33.
The graph of the density of tumor cells confirms the initial reduction in
tumor size and the consequent recovery. There is a sharp increase between
t=50 (after the diffusion stabilization) and t = 200. From that point the
curve increases slightly, is not linear and shows some fluctuations, each rise
corresponds to the time when the tumor has moved towards the capillary.
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Figure 34: Cells Phases at t=10 (left) and t=100 (right), Mφ=5, G=0.05
and A=0.2
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Figure 35: Cells Phases at t=500 (left) and t=1000 (right), Mφ=5, G=0.05
and A=0.2
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Figure 36: Cells Phases at t=1500 (left) and t=2000 (right), Mφ=5, G=0.05
and A=0.2
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Figure 37: Evolution of ρt in time: Mφ=5, G=0.05 and A=0.2
By increasing the death rate we wanted to check if the tumor was able
to recover after the initial reduction of the size and proliferate in the same
way as above and verify what its influence on the fluctuations of the density
graph.
Checking the figures 34, 35 and 36 we can note that tumor is able to
recover, despite its size has reduced more than the previous case. The tumor
does not grow so much, as we expected as A is greater, but behaves similarly.
Comparing the figures 37 and 33 we can notice that after t=50 both start
to grow again, however, the density of tumor cells in the first graph have the
minimum on ρt ≃0.015 while in the second is on ρt ≃0.012, which corrob-
orates the fact that the death rate of it cells is higher. The peak in figure
37 is more acentuated than in figure 33 and the system stabilizes at t=300
rather than ate t=200. We observe the same fluctuations, corresponding to
the movement of the tumor within the space, but in fact the fluctuations
decrease with time.
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Figure 38: Cells Phases at t=10 (left) and t=100 (right), Mφ=5, G=0.2 and
A=0.2
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Figure 39: Cells Phases at t=500 (left) and t=1000 (right), Mφ=5, G=0.2
and A=0.2
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Figure 40: Cells Phases at t=1500 (left) and t=2000 (right), Mφ=5, G=0.2
and A=0.2
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In order to verify if the tumor always behave in the way described earlier
when Mφ=5, we decided to increase the growth rate while maintaining the
A high.
In this particular case as we note at figures 38, 39 and 40 the tumor
behaves like the other situations in which it had high growth rate, regardless
of the mobility. Its shape is closer to the case where mobility was equal to
1, but phase separation is more visible like in the case where Mφ=10.
The objective of ensuring that the tumor growth cease occurred only in
the case of graphs of figures 33 and 37, and only partially.
The growth and apoptosis rates could vary between 0 and 1, but above
0.1 is considered a high rate. For Mφ we tested values between 0 and 20,
but the results more presentable are placed in the interval [1;10].
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5 Final Remarks/Further Work
The tumor cells arise in our body as a result of successive cell divisions
after an initial set of mutations which target important regulatory processes
of a single cell [15, 18]. This abnormal growth of a mass of cells requires
space to develop and grow. Because the cells of the body are in an orga-
nized lattice, these abnormal cells have to overcome several factors to get
developed.
The tumor has to overcome the immune system so that its cells can sur-
vive, must overcome the external pressures exerted by the extracelullar ma-
trix and the body’s own cells to be able to proliferate and has yet to develop
mechanisms in order to acquire the amount of nutrient needed to feed its
cells and to produce new cells by cell division [51, 52, 53, 54, 55, 56].
That is the reason why tumor cells need more nutrients then normal cells,
because they are always fighting to survive in an environment in which they
are strange.
Attempting to reproduce the biological microenvironments through a com-
putational model is really a great challenge because we can always add more
variables, more interactions, to attempt a description closer to the real prob-
lem.
During this project we built the computational model by steps, starting
with a very simple model, then adding parameters and variables until we
reach the final model, which can always be improved.
At this point we can include the factor VEGF, produced at the tumor
and diffusing in the ECM, in order to include angiogenesis. Thus the model
would examine the tumor from its avascular phase until the time it becomes
vascular.
Now the model only studies the tumor’s avascular stage, being nourish by
a blood vessel present in the system.
Tumor cells proliferate in a normal tissue that is deformable and let the
tumor grow and even move. But normal cells do not allow the tumor to
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have total freedom of movement, becuse they form an ordered lattice. Fur-
thermore, the cellular matrix hinders the proliferation of the tumor while
keeping the cell density in the space of study, constant over time.
We observe that the duplication of tumor cells through cell division, in-
creasing the cell density of the tumor results on the compression of normal
tissue.
After numerous simulations we verified that the tumor adapts it shape to
achieve the maximum nutrient possible and be able to proliferate.
In the graphs of tumor cell density we could note that ρt do not stay con-
stant how we expect, at a certain point. Instead of that, it have some ripples
due to an interesting behavior. When the tumor stops having enought nu-
trient and would have to arrests its growth remaining in a steady state of
proliferation, it moves towards the vessel. There it can grow a bit more until
it reaches a new steady.
Hence, due to the anisotropy of nutrient distribution, we do not verify the
arrest of tumor growth.
In a biological environment when the tumor reaches a steady state, it
develops new features that allow it to continue increasing and proliferate.
The most common is that tumor induces angiogenesis, but in the cases
it is treated with angiogenesis-suppressors tumor often find other ways to
proliferate such as developing mechanisms to adapt to the now changed
environment or metastize.
In this system the tumor moved towards the vessel to continue increasing
its size and would not, in principle, require angiogenesis at this step to
proceed its development.
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Appendix
A Deduction of Equation (5)
Using the Ginzburg-Landau free energy to describe the ordered phase [50]:
F [φ(−→r )] =
∫
(V (φ(−→r )) + ε
2
2
|∇φ(−→r )|2)d−→r (17)
Where V(φ(−→r ))is a potential and has a double-well structure. In the
model presented:
V (φ(−→r )) = −φ(
−→r )2
2
+
φ(−→r )4
4
(18)
In order to have the minimal potential located in φ = ±1.
F [φ(−→r )] =
∫
(−φ(
−→r )2
2
+
φ(−→r )4
4
+
ε2
2
|∇φ(−→r )|2)d−→r (19)
When the order parameter is conserved [50]:
∂φ
∂t
= ∇2 δF
δφ
= ∇2µ(φ) (20)
Where µ(φ) is the chemical potential, and:
µ(φ) =
δF
δφ
(21)
δF [φ(−→r )] =
∫
δF [φ(−→r )]
δφ(−→r ) δφ(
−→r )d−→r (22)
F [φ+ δφ] =
∫
(−(φ+ δφ)
2
2
+
(φ+ δφ)4
4
+
ε2
2
|∇(φ+ δφ)|2)d−→r(23)
⇔ F [φ+ δφ] =
∫
(−φ
2 + 2φδφ
2
+
φ4 + 4φ3δφ
4
+
+
ε2
2
(|∇φ|2 + |2∇φ∇δφ|))d−→r
⇔ F [φ+ δφ] =
∫
(−φ
2
2
+
φ4
4
+
ε2
2
|∇φ|2)d−→r +
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+∫
(−φδφ+ φ3δφ+ ε2|∇φ∇δφ|)d−→r
⇔ F [φ+ δφ] = F [φ] +
∫
(−φδφ+ φ3δφ+ ε2|∇φ∇δφ|)d−→r
(24)
Integrating |∇φ∇δφ| by parts:
⇔ F [φ+ δφ] = F [φ] +
∫
(δφ(−φ + φ3 − ε2|∇φ|2))d−→r
⇔ F [φ+ δφ]− F [φ] =
∫
((−φ+ φ3 − ε2|∇φ|2)δφ)d−→r
⇔ δF =
∫
(µ(φ)δφ)d−→r (25)
Where the chemical potential is given by:
µ(φ) = −φ+ φ3 − ε2|∇φ|2
⇔ µ(φ) = −φ+ φ3 − ε2∇2φ2 (26)
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B Deduction of Equation (8), (9) and (12)
Considering the following equations for the dynamics of tumor and normal
cells, that include phase-separation (first term), diffusion (second term) and
tumor cells proliferation (parameter L):
∂tρt =
Mφ
2
∇2µ+Mρ∇2ρt + L (27)
∂tρn = −Mφ
2
∇2µ+Mρ∇2ρn (28)
We can derivate the equations for ρ and φ defined by:
ρ = ρt + ρn (29)
φ =
ρt − ρn
ρt + ρn
(30)
⇔ φ = ρt − ρn
ρ
(31)
For ρ we obtain:
∂tρ = ∂tρt + ∂tρn (32)
⇔ ∂tρ =Mρ∇2ρt +Mρ∇2ρn + L
⇔ ∂tρ =Mρ∇2ρ+ L (33)
And finally for φ we get:
∂tφ =
∂t(ρt − ρn)(ρt + ρn)− ∂t(ρt + ρn)(ρt − ρn)
(ρt + ρn)2
(34)
⇔ ∂tφ = ∂t(ρt − ρn)ρ− ∂tρ(ρt − ρn)
ρ2
⇔ ∂tφ = (∂tρt − ∂tρn)ρ− ∂tρ(φρ)
ρ2
⇔ ∂tφ = ∂tρt − ∂tρn − ∂tρ(φ)
ρ
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⇔ ∂tφ =
Mφ
2 ∇2µ+Mρ∇2ρt + L+
Mφ
2 ∇2µ−Mρ∇2ρn − φ(Mρ∇2ρ+ L)
ρ
⇔ ∂tφ =
Mφ
2 ∇2µ+Mρ∇2ρt + L+
Mφ
2 ∇2µ−Mρ∇2ρn − φ(Mρ∇2ρ+ L)
ρ
⇔ ∂tφ = Mφ∇
2µ+Mρ∇2ρt −Mρ∇2ρn −Mρφ∇2ρ+ L(1− φ)
ρ
⇔ ∂tφ = Mφ∇
2µ+Mρ∇2(φρ)−Mρφ∇2ρ+ L(1− φ)
ρ
⇔ ∂tφ = Mφ
ρ
∇2µ+ Mρ
ρ
∇2(φρ) − Mρ
ρ
φ∇2ρ+ L(1− φ
ρ
)
⇔ ∂tφ = Mφ
ρ
∇2µ+ Mρ
ρ
∇2(φρ) − Mρ
ρ
φ∇2ρ+G (35)
Where:
G = L
(1− φ)
ρ
(36)
⇔ G =


Gφρ(1 − ρ) (1−φ)
ρ
, φ ≥ 0, n > 0
−Aρ(1 + φ) (1−φ)
ρ
, φ > −1, n = 0
0 , φ < 0, n > 0
⇔ G =


Gφ(1 − ρ)(1− φ) , φ ≥ 0, n > 0
−A(1− φ2) , φ > −1, n = 0
0 , φ < 0, n > 0
(37)
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C Deduction of Equation (10) and (11)
∂t(φρ) = ρ∂tφ+ φ∂tρ (38)
⇔ ∂t(φρ) = Mφρ
ρ
∇2µ+ Mρρ
ρ
∇2(φρ) − Mρρ
ρ
φ∇2ρ+Gρ+Mρφ∇2ρ+
+ Lφ
⇔ ∂t(φρ) =Mφ∇2µ+Mρ∇2(φρ)−Mρφ∇2ρ+Gρ+Mρφ∇2ρ+
+ Lφ
⇔ ∂t(φρ) =Mφ∇2µ+Mρ∇2(φρ)−Mρφ∇2ρ+Mρφ∇2ρ+H (39)
Where we introduce:
H = Lρ+Gφ (40)
48
D First Computational Model
!Continuous Model with multiple points
PROGRAM ContModel
IMPLICIT NONE
!Initialize variables
INTEGER :: x, y, w, r, z
REAL :: D, a, Dt, t, H, St, Gr, Dr, s, V2MU, MV2U, UV2M
!Initialize matrices
REAL, ALLOCATABLE :: F(:,:), N(:,:), U(:,:), M(:,:)
REAL, ALLOCATABLE :: V2N(:,:), V2F(:,:)
!Program Structure
CALL ini_arrays()
DO w = 1, int(t/Dt)
CALL nut_dif()
CALL grow_tum
END DO
CONTAINS
!Program Contents (Sub-Routines)
SUBROUTINE ini_arrays()
INTEGER :: i,j
!Insert Constant’s Values
PRINT *, ’Enter x dimension of box: ’
READ *, x
PRINT *, ’Enter y dimension of box: ’
READ *, y
PRINT *, ’Enter tumour radius: ’
READ *, r
PRINT *, ’Enter Diffusion Cte: ’
READ *, D
PRINT *, ’Enter Alfa: ’
READ *, a
PRINT *, ’Enter Interface Energy: ’
READ *,H
PRINT *, ’Enter Growth Rate: ’
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READ *, Gr
PRINT *, ’Enter Death Rate: ’
READ *, Dr
PRINT *, ’Enter Final Time: ’
READ *, t
PRINT *, ’Enter Step for Print: ’
READ *, St
Dt = 1/(4*16*(3.141592**4))
PRINT *, ’Dt =’,Dt
PRINT *, int(St/Dt), ’Step for save (N of Iterations)’
PRINT *, int(t/Dt), ’Total of Iterations’
!Allocate all matrices to use in other sub-routines
ALLOCATE (F(x,y))
ALLOCATE (N(x,y))
ALLOCATE (V2N(x,y))
ALLOCATE (V2F(x,y))
ALLOCATE (U(x,y))
ALLOCATE (M(x,y))
OPEN (15, FILE=’Cn.dat’, ACTION=’write’)
OPEN (17, FILE=’Cg.dat’, ACTION=’write’)
write(15,*)
write(17,*)
CLOSE (15)
CLOSE (17)
!Fill in cell and nutrient matrices
DO j=1, y
DO i=1, x
N(i,j)=(i/100)
IF (i==x) THEN
N(i,j)=1
END IF
END DO
END DO
!Create tumor with radius r
DO j=1, y
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DO i=1, x
F(i,j)=-tanh((sqrt(real(((i-(x/4))**2+(j-(y/2))**2)))-r)/1.0)
END DO
END DO
END SUBROUTINE ini_arrays
FUNCTION fx(i)
IMPLICIT NONE
INTEGER, INTENT (IN) :: i
INTEGER :: fx
IF (i>x) THEN
fx=2*x-i
ELSE IF (i<1) THEN
fx=2-i
ELSE
fx=i
END IF
END FUNCTION fx
FUNCTION fy(j)
IMPLICIT NONE
INTEGER, INTENT (IN) :: j
INTEGER :: fy
IF (j>y) THEN
fy=2*y-j
ELSE IF (j<1) THEN
fy=2-j
ELSE
fy=j
END IF
END FUNCTION fy
SUBROUTINE nut_dif()
INTEGER :: i,j
!Represent Nutrient diffusion
DO j=1, y
DO i=1 , x
!Laplacian
V2N(i,j)=N(fx(i+1),j)+N(fx(i-1),j)+N(i,fy(j+1))+N(i,fy(j-1))
-4*N(i,j)
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!Diffusion’s Equation
IF (F(i,j)>=0) THEN
z=10
ELSE
z=0.1
END IF
N(i,j)=N(i,j)+(V2N(i,j)*D-z*a)*Dt
IF (N(i,j)<=0) THEN
N(i,j)=0
ELSE IF (i==x) THEN
N(i,j)=1
END IF
END DO
END DO
! Save diffusion’s plot for several time’s steps
IF (MOD (w ,int((St+0.00001)/Dt))==0) THEN
OPEN (15, FILE=’Cn.dat’, STATUS=’old’, POSITION=’append’)
DO j=1, y
write (15,*) N(:,j)
END DO
write (15,*)
CLOSE (15)
END IF
END SUBROUTINE nut_dif
SUBROUTINE grow_tum
INTEGER :: i,j
!Represent Tumour Growth
DO j=1, y
DO i=1,x
V2F(i,j)=F(fx(i+1),j)+F(fx(i-1),j)+F(i,fy(j+1))+F(i,fy(j-1))
-4*F(i,j)
U(i,j)=F(i,j)*(F(i,j)*F(i,j)-1)-V2F(i,j)*(H**2)
!Define cell’s Mobility
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IF (F(i,j)>=0) THEN
M(i,j)=1
ELSE
M(i,j)=0.1
END IF
END DO
END DO
DO j=1, y
DO i=1, x
V2MU=M(fx(i+1),j)*U(fx(i+1),j)+M(fx(i-1),j)*U(fx(i-1),j)
+M(i,fy(j+1))*U(i,fy(j+1))+M(i,fy(j-1))*U(i,fy(j-1))
-4*M(i,j)*U(i,j)
MV2U=M(i,j)*(U(fx(i+1),j)+U(fx(i-1),j)+U(i,fy(j+1))
+U(i,fy(j-1)))
UV2M=U(i,j)*(M(fx(i+1),j)+M(fx(i-1),j)+M(i,fy(j+1))
+M(i,fy(j-1)))
IF (F(i,j)>=0 .AND. N(i,j)>0.0000001) THEN
s=Gr
ELSE IF (F(i,j)<=-1) THEN
s=0
ELSE
s=-Dr
END IF
F(i,j)=F(i,j)+(0.5*(V2MU+MV2U-UV2M)+s)*Dt
END DO
END DO
IF (MOD (w ,int((St+0.00001)/Dt))==0) THEN
OPEN (17, FILE=’Cg.dat’, STATUS=’old’, POSITION=’append’)
DO j=1, y
write (17,*) F(:,j)
END DO
write (17,*)
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CLOSE (17)
END IF
END SUBROUTINE grow_tum
END PROGRAM ContModel
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E Second Computational Model
!Continuous Model with multiple points
PROGRAM ContModel
IMPLICIT NONE
!Initialize variables
INTEGER :: x, y, w, r, z
REAL :: D, a, Dt, t, H, St, Gr, Dr, L, G, M1, M2
REAL :: AvRo, AvRoF
!Initialize matrices
REAL, ALLOCATABLE :: F(:,:), N(:,:), U(:,:), Ro(:,:), V2R(:,:), V2U(:,:)
REAL, ALLOCATABLE :: V2N(:,:), V2F(:,:), Mf(:,:), Mro(:,:), V2RF(:,:)
!Program Structure
CALL ini_arrays()
DO w = 1, int(t/Dt)
CALL nut_dif()
CALL grow_tum
END DO
CONTAINS
!Program Contents (Sub-Routines)
SUBROUTINE ini_arrays()
INTEGER :: i,j
OPEN (13, FILE=’val.txt’, ACTION=’read’)
READ (13,*) M1
READ (13,*) Gr
READ (13,*) Dr
CLOSE(13)
Dt = 1/(5*16*(3.141592**4))
x=100
y=100
r=10
t=2000
St=1
D=35.0
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a=0.014
H=1.0
M2=1.0
OPEN (14, FILE=’Paramet.dat’, ACTION=’write’)
write(14,*) ’x =’,x
write(14,*) ’y =’,y
write(14,*) ’r =’,r
write(14,*) ’D =’,D
write(14,*) ’a =’,a
write(14,*) ’H =’,H
write(14,*) ’M1 =’,M1
write(14,*) ’M2 =’,M2
write(14,*) ’Gr =’,Gr
write(14,*) ’Dr =’,Dr
write(14,*) ’t =’,t
write(14,*) ’St =’,St
write(14,*) ’Dt =’,Dt
write(14,*) int(St/Dt), ’Step for save (N of Iterations)’
write(14,*) int(t/Dt), ’Total of Iterations’
CLOSE (14)
!Allocate all matrices to use in other sub-routines
ALLOCATE (F(x,y))
ALLOCATE (N(x,y))
ALLOCATE (V2N(x,y))
ALLOCATE (V2F(x,y))
ALLOCATE (U(x,y))
ALLOCATE (Mf(x,y))
ALLOCATE (Ro(x,y))
ALLOCATE (Mro(x,y))
ALLOCATE (V2R(x,y))
ALLOCATE (V2RF(x,y))
ALLOCATE (V2U(x,y))
OPEN (15, FILE=’Cn.dat’, ACTION=’write’)
!OPEN (16, FILE=’Cro.dat’, ACTION=’write’)
OPEN (17, FILE=’Cg.dat’, ACTION=’write’)
OPEN (18, FILE=’Ct.dat’, ACTION=’write’)
OPEN (19, FILE=’RoT.dat’, ACTION=’write’)
OPEN (20, FILE=’RoS.dat’, ACTION=’write’)
write(15,*)
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!write(16,*)
write(17,*)
write(18,*)
write(19,*)
write(20,*)
CLOSE (15)
!CLOSE (16)
CLOSE (17)
CLOSE (18)
CLOSE (19)
CLOSE (20)
!Fill in cell and nutrient matrices
DO j=1, y
DO i=1, x
N(i,j)=(i*1.0)/x
IF (i==x) THEN
N(i,j)=1
END IF
END DO
END DO
!Create tumor with radius r
DO j=1, y
DO i=1, x
Ro(i,j)=0.5
F(i,j)=-tanh((sqrt(real(((i-(x/4))**2+(j-(y/2))**2)))-r)/1.0)
END DO
END DO
END SUBROUTINE ini_arrays
FUNCTION fx(i)
IMPLICIT NONE
INTEGER, INTENT (IN) :: i
INTEGER :: fx
IF (i>x) THEN
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fx=2*x-i
ELSE IF (i<1) THEN
fx=2-i
ELSE
fx=i
END IF
END FUNCTION fx
FUNCTION fy(j)
IMPLICIT NONE
INTEGER, INTENT (IN) :: j
INTEGER :: fy
IF (j>y) THEN
fy=2*y-j
ELSE IF (j<1) THEN
fy=2-j
ELSE
fy=j
END IF
END FUNCTION fy
SUBROUTINE nut_dif()
INTEGER :: i,j
!Represent Nutrient diffusion
DO j=1, y
DO i=1 , x
!Laplacian
V2N(i,j)=N(fx(i+1),j)+N(fx(i-1),j)+N(i,fy(j+1))+N(i,fy(j-1))
-4*N(i,j)
END DO
END DO
DO j=1, y
DO i=1 , x
!Diffusion’s Equation
IF (F(i,j)>=0) THEN
z=14
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ELSE
z=0.1
END IF
N(i,j)=N(i,j)+(V2N(i,j)*D-z*a)*Dt
IF (N(i,j)<=0) THEN
N(i,j)=0
ELSE IF (i==x) THEN
N(i,j)=1
END IF
END DO
END DO
! Save diffusion’s plot for several time’s steps
IF (MOD (w ,int((10*St+0.00001)/Dt))==0) THEN
OPEN (15, FILE=’Cn.dat’, STATUS=’old’, POSITION=’append’)
DO j=1, y
write (15,*) N(:,j)
END DO
write (15,*)
CLOSE (15)
END IF
END SUBROUTINE nut_dif
SUBROUTINE grow_tum
INTEGER :: i,j
!Represent Tumour Growth
DO j=1, y
DO i=1,x
V2F(i,j)=F(fx(i+1),j)+F(fx(i-1),j)+F(i,fy(j+1))+F(i,fy(j-1))
-4*F(i,j)
U(i,j)=F(i,j)*(F(i,j)*F(i,j)-1)-V2F(i,j)*(H**2)
!Define Mobilities
Mf(i,j)=M1
Mro(i,j)=M2
END DO
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END DO
AvRo=0
AvRoF=0
DO j=1, y
DO i=1, x
V2U(i,j)=U(fx(i+1),j)+U(fx(i-1),j)+U(i,fy(j+1))+U(i,fy(j-1))
-4*U(i,j)
V2R(i,j)=Ro(fx(i+1),j)+Ro(fx(i-1),j)+Ro(i,fy(j+1))+Ro(i,fy(j-1))
-4*Ro(i,j)
V2RF(i,j)=Ro(fx(i+1),j)*F(fx(i+1),j)+Ro(fx(i-1),j)*F(fx(i-1),j)
+Ro(i,fy(j+1))*F(i,fy(j+1))+Ro(i,fy(j-1))*F(i,fy(j-1))
END DO
END DO
DO j=1, y
DO i=1,x
IF (F(i,j)>=0 .AND. N(i,j)>0.0000001) THEN
G=Gr*F(i,j)*(1-F(i,j))*(1-Ro(i,j))
L=Gr*F(i,j)*Ro(i,j)*(1-Ro(i,j))
ELSE IF ((F(i,j)<=-1) .OR.(F(i,j)<0 .AND. N(i,j)>0.0000001))
THEN
G=0
L=0
ELSE
G=-Dr*(1-F(i,j)**2)
L=-Dr*(1+F(i,j))*Ro(i,j)
END IF
IF (Ro(i,j)<0.001) THEN
F(i,j)=F(i,j)+((-F(i,j)*Mro(i,j)*V2R(i,j)+Mf(i,j)*V2U(i,j)
+Mro(i,j)*V2RF(i,j))/0.001+G)*Dt
ELSE
F(i,j)=F(i,j)+((-F(i,j)*Mro(i,j)*V2R(i,j)+Mf(i,j)*V2U(i,j)
+Mro(i,j)*V2RF(i,j))/Ro(i,j)+G)*Dt
END IF
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Ro(i,j)=Ro(i,j)+(Mro(i,j)*V2R(i,j)+L)*Dt
AvRo=AvRo+Ro(i,j)
AvRoF=AvRoF+Ro(i,j)*F(i,j)
END DO
END DO
AvRo=AvRo/(x*y)
AvRoF=AvRoF/(x*y)
IF (MOD (w ,int((St+0.00001)/Dt))==0) THEN
OPEN (19, FILE=’RoT.dat’, STATUS=’old’, POSITION=’append’)
OPEN (20, FILE=’RoS.dat’, STATUS=’old’, POSITION=’append’)
write (19,*) (AvRoF+AvRo)/2
write (20,*) (AvRo-AvRoF)/2
CLOSE (19)
CLOSE (20)
END IF
IF (MOD (w ,int((10*St+0.00001)/Dt))==0) THEN
!OPEN (16, FILE=’Cro.dat’, STATUS=’old’, POSITION=’append’)
OPEN (17, FILE=’Cg.dat’, STATUS=’old’, POSITION=’append’)
OPEN (18, FILE=’Ct.dat’, STATUS=’old’, POSITION=’append’)
DO j=1, y
!write (16,*) Ro(:,j)
write (17,*) F(:,j)
write (18,*) (F(:,j)+1)*Ro(:,j)/2.0
END DO
!write (16,*)
write (17,*)
write (18,*)
!CLOSE (16)
CLOSE (17)
CLOSE (18)
END IF
END SUBROUTINE grow_tum
END PROGRAM ContModel
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